Samarth Kulkarni - 22 Jun 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
22 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 17:07:48 UTC
Previous filing
12 Jun 2023
Next filing
17 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +48,000 $0.000000 48,000 22 Jun 2023 Ordinary Shares 48,000 $6.35 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.